Literature DB >> 17951359

Pathophysiology and fate of hepatocytes in a mouse model of mitochondrial hepatopathies.

F Diaz1, S Garcia, D Hernandez, A Regev, A Rebelo, J Oca-Cossio, C T Moraes.   

Abstract

BACKGROUND: Although oxidative phosphorylation defects can affect the liver, these conditions are poorly understood, partially because of the lack of animal models. AIMS: To create and characterise the pathophysiology of mitochondrial hepatopathies in a mouse model.
METHODS: A mouse model of mitochondrial hepatopathies was created by the conditional liver knockout (KO) of the COX10 gene, which is required for cytochrome c oxidase (COX) function. The onset and progression of biochemical, molecular and clinical phenotypes were analysed in several groups of animals, mostly at postnatal days 23, 56, 78 and 155.
RESULTS: Biochemical and histochemical analysis of liver samples from 23-56-day-old KO mice showed liver dysfunction, a severe COX deficiency, marked mitochondrial proliferation and lipid accumulation. Despite these defects, the COX-deficient hepatocytes were not immediately eliminated, and apoptosis followed by liver regeneration could be observed only at age 78 days. Hepatocytes from 56-78-day-old KO mice survived despite very low COX activity but showed a progressive depletion of glycogen stores. In most animals, hepatocytes that escaped COX10 ablation were able to proliferate and completely regenerate the liver between days 78 and 155.
CONCLUSIONS: The results showed that when faced with a severe oxidative phosphorylation defect, hepatocytes in vivo can rely on glycolysis/glycogenolysis for their bioenergetic needs for relatively long periods. Ultimately, defective hepatocytes undergo apoptosis and are replaced by COX-positive cells first observed in the perivascular regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951359      PMCID: PMC2730640          DOI: 10.1136/gut.2006.119180

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  39 in total

1.  DNA excision in liver by an albumin-Cre transgene occurs progressively with age.

Authors:  C Postic; M A Magnuson
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

Review 2.  In vivo and in organello assessment of OXPHOS activities.

Authors:  Antoni Barrientos
Journal:  Methods       Date:  2002-04       Impact factor: 3.608

3.  Hepatic HNF4alpha deficiency induces periportal expression of glutamine synthetase and other pericentral enzymes.

Authors:  Vesna S Stanulović; Irene Kyrmizi; Marianna Kruithof-de Julio; Maarten Hoogenkamp; Jacqueline L M Vermeulen; Jan M Ruijter; Iannis Talianidis; Theodorus B M Hakvoort; Wouter H Lamers
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

Review 4.  Assay of mitochondrial ATP synthesis in animal cells and tissues.

Authors:  Cristofol Vives-Bauza; Lichuan Yang; Giovanni Manfredi
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

5.  Glucose loading during primary culture has opposite effects on the viability of hepatocytes exposed to potassium cyanide and to iodoacetic acid.

Authors:  K Shiroyama; K Moriwaki; S Kusunoki; N Saeki; O Yuge
Journal:  Metabolism       Date:  2001-03       Impact factor: 8.694

6.  Anti-apoptotic function of gelsolin in fas antibody-induced liver failure in vivo.

Authors:  Ludger Leifeld; Klaus Fink; Grazyna Debska; Magdalene Fielenbach; Volker Schmitz; Tilman Sauerbruch; Ulrich Spengler
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

7.  Mice lacking bi-1 gene show accelerated liver regeneration.

Authors:  Béatrice Bailly-Maitre; Emilie Bard-Chapeau; Fréderic Luciano; Nathalie Droin; Jean-Marie Bruey; Benjamin Faustin; Christina Kress; Juan M Zapata; John C Reed
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency.

Authors:  Francisca Diaz; Christine K Thomas; Sofia Garcia; Dayami Hernandez; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2005-08-15       Impact factor: 6.150

9.  Extrahepatic cells contribute to the progenitor/stem cell response following reduced-size liver transplantation in mice.

Authors:  Lars O Conzelmann; Ian N Hines; Michael Kremer; Ashley W Perry; John J Lemasters; Michael D Wheeler
Journal:  Exp Biol Med (Maywood)       Date:  2007-04

Review 10.  Mitochondrial hepatopathies.

Authors:  S K Bandyopadhyay; Anita Dutta
Journal:  J Assoc Physicians India       Date:  2005-11
View more
  24 in total

1.  Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.

Authors:  Ursula Fünfschilling; Lotti M Supplie; Don Mahad; Susann Boretius; Aiman S Saab; Julia Edgar; Bastian G Brinkmann; Celia M Kassmann; Iva D Tzvetanova; Wiebke Möbius; Francisca Diaz; Dies Meijer; Ueli Suter; Bernd Hamprecht; Michael W Sereda; Carlos T Moraes; Jens Frahm; Sandra Goebbels; Klaus-Armin Nave
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

Review 2.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

Review 3.  Schwann cell mitochondria as key regulators in the development and maintenance of peripheral nerve axons.

Authors:  Daisuke Ino; Masamitsu Iino
Journal:  Cell Mol Life Sci       Date:  2016-09-16       Impact factor: 9.261

Review 4.  Mitochondrial biogenesis and turnover.

Authors:  Francisca Diaz; Carlos T Moraes
Journal:  Cell Calcium       Date:  2008-04-18       Impact factor: 6.817

5.  Cells lacking Rieske iron-sulfur protein have a reactive oxygen species-associated decrease in respiratory complexes I and IV.

Authors:  Francisca Diaz; José Antonio Enríquez; Carlos T Moraes
Journal:  Mol Cell Biol       Date:  2011-11-21       Impact factor: 4.272

6.  Lipidomics unveils lipid dyshomeostasis and low circulating plasmalogens as biomarkers in a monogenic mitochondrial disorder.

Authors:  Matthieu Ruiz; Alexanne Cuillerier; Caroline Daneault; Sonia Deschênes; Isabelle Robillard Frayne; Bertrand Bouchard; Anik Forest; Julie Thompson Legault; Frederic M Vaz; John D Rioux; Yan Burelle; Christine Des Rosiers
Journal:  JCI Insight       Date:  2019-07-25

7.  Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.

Authors:  Tina Wenz; Francisca Diaz; Bruce M Spiegelman; Carlos T Moraes
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

Review 8.  Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.

Authors:  Alessandra Torraco; Francisca Diaz; Uma D Vempati; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2008-06-13

Review 9.  The pathophysiology of mitochondrial disease as modeled in the mouse.

Authors:  Douglas C Wallace; Weiwei Fan
Journal:  Genes Dev       Date:  2009-08-01       Impact factor: 11.361

10.  Mouse models of oxidative phosphorylation dysfunction and disease.

Authors:  Uma D Vempati; Alessandra Torraco; Carlos T Moraes
Journal:  Methods       Date:  2008-10-10       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.